[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN) BofA Securities 2025 Healthcare Conference (Transcript)",
    "summary": "Regeneron Pharmaceuticals, Inc. (REGN) BofA Securities 2025 Healthcare Conference (Transcript)",
    "url": "https://finnhub.io/api/news?id=6a19c6b6bff6f755a5fb4994e84a50ad7c19674c0260fd81a6f8db1afe2c535d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747150981,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN) BofA Securities 2025 Healthcare Conference (Transcript)",
      "id": 134410320,
      "image": "",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=6a19c6b6bff6f755a5fb4994e84a50ad7c19674c0260fd81a6f8db1afe2c535d"
    }
  },
  {
    "ts": null,
    "headline": "REGN Q1 Earnings Call: Pipeline Progress and EYLEA Headwinds Dominate Discussion",
    "summary": "Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $3.03 billion. Its non-GAAP profit of $8.22 per share was 3% below analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=8bbc0a58660b17a2939a19d6bd181ee36c2d998f322bc2416f76ba65fd73876b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747131386,
      "headline": "REGN Q1 Earnings Call: Pipeline Progress and EYLEA Headwinds Dominate Discussion",
      "id": 134409473,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $3.03 billion. Its non-GAAP profit of $8.22 per share was 3% below analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=8bbc0a58660b17a2939a19d6bd181ee36c2d998f322bc2416f76ba65fd73876b"
    }
  }
]